Konservative Therapie der peripheren arteriellen Verschlusskrankheit

When and How to Combine Antiplatelet and Anticoagulant Drugs?

(2022) Christine Espinola-Klein   Hamostaseologie

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy

(2021) Victor Aboyans et al.   EUROPEAN HEART JOURNAL

The tobacco endgame—eradicating a worsening epidemic

(2021) Jeffrey Willett et al.   EUROPEAN HEART JOURNAL

Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease

(2021) Karsten Keller et al.   Journal of Clinical Medicine

Rivaroxaban in Peripheral Artery Disease after Revascularization

(2020) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

(2020) Daniele Pastori et al.   THROMBOSIS AND HAEMOSTASIS

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2019) Francesco Cosentino et al.   EUROPEAN HEART JOURNAL

Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis

(2019) Peige Song et al.   Lancet Global Health

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

(2018) Winfried März et al.   ATHEROSCLEROSIS

Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease

(2018) Shipra Arya et al.   CIRCULATION

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

(2018) Sonia S Anand et al.   LANCET

Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization

(2018) Connie N. Hess et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

(2017) Victor Aboyans et al.   EUROPEAN HEART JOURNAL

Efficacy and Safety of Alprostadil in Patients with Peripheral Arterial Occlusive Disease Fontaine Stage IV: Results of a Placebo Controlled Randomised Multicentre Trial (ESPECIAL)

(2017) H. Lawall et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease

(2017) Marc P. Bonaca et al.   CIRCULATION

Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease

(2017) Subodh Verma et al.   CIRCULATION

Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication

(2013) Anna A. Ahimastos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION